Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Hatteras Venture Partners Honors HistoSonics with the Charles A. Sanders Award for Entrepreneurial Excellence
From Hatteras Venture Partners
Via GlobeNewswire
Feed a Family of 10 for Under $40 this Thanksgiving: Stop & Shop Introduces One of the Season’s Best Dinner Deals
From Stop and Shop
Via GlobeNewswire
Inriver Expands Connected Ecosystem for Product Content Distribution Through New Partnerships with Shopify and Affiliated Distributors
From inRiver Inc
Via GlobeNewswire
Celldex Presents Additional Positive Data Demonstrating Barzolvolimab’s Ability to Drive Rapid, Profound and Durable Complete Urticaria Control in Phase 2 Chronic Spontaneous Urticaria (CSU) Study
From Celldex Therapeutics, Inc.
Via GlobeNewswire
Tickers CLDX
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Tickers IOVA
UroGen Reports Third Quarter 2025 Financial Results as ZUSDURI™ Launch Gains Momentum
From UroGen Pharma Ltd.
Via GlobeNewswire
Tickers URGN
SunCar’s Investment in its AI Technology Development Center Driving Strong Premium Sales for its EV Partners
From SunCar Technology Group Inc.
Via GlobeNewswire
Tickers SDA SDAWW
Healthcare Minus the Headache: RokketMed, A Solution to Finding the Care That Counts
From RokketMed
Via GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Tickers PRAX
Solmate Infrastructure (SLMT) Launches the UAE’s First Performant Solana Validator, Announces Infrastructure Flywheel™ Including Planned RPC and Colocation Services
From Solmate Infrastructure
Via GlobeNewswire
Tickers SLMT
Lisata Therapeutics Wins 2025 BioTech Breakthrough Award for ‘Overall BioPharma Solution of the Year’
From Lisata Therapeutics, Inc.
Via GlobeNewswire
Tickers LSTA
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
From CYTOMED THERAPEUTICS LIMITED
Via GlobeNewswire
Tickers GDTC
Darktrace Recognized as the Only Customer’s Choice Vendor in the 2025 Gartner® Peer Insights™ for Network Detection and Response
From Darktrace
Via GlobeNewswire
RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
From RAPT Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPT
Nanox Collaborates with Leading Czech Medical Imaging Distributor EXRAY to Expand European Footprint
From Nano-X Imaging Ltd
Via GlobeNewswire
Tickers NNOX
Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program
From Annovis Bio Inc.
Via GlobeNewswire
Tickers ANVS
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
From Chemomab Therapeutics
Via GlobeNewswire
Tickers CMMB
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Jamf Holding Corp. (Nasdaq – JAMF), CSG Systems International, Inc. (Nasdaq – CSGS), Olympic Steel, Inc. (Nasdaq – ZEUS), Heidrick & Struggles International, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
Tickers CSGS HSII JAMF ZEUS
*MEDIA ALERT* Verizon and David Beckham Launch First-Ever "Golden Ticket" Sweepstakes for FIFA World Cup 26™
From Verizon Communications, Inc.
Via GlobeNewswire
Tickers VZ
Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
From Replimune, Inc.
Via GlobeNewswire
Tickers REPL
Zscaler to Host First Quarter Fiscal Year 2026 Earnings Conference Call
From Zscaler, Inc.
Via GlobeNewswire
Tickers ZS
Webinar to Explore Solutions for Sustainable Energy and Technology to Power a Resilient Economy
From Engine Technology Forum
Via GlobeNewswire
Celldex Presents Results from Barzolvolimab Phase 2 Study in Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Demonstrating Sustained Efficacy and Favorable Safety Profile over 20 Week Placebo Controlled Treatment Period; Up to 66% of Patients
From Celldex Therapeutics, Inc.
Via GlobeNewswire
Tickers CLDX
Gaxos Labs Launches “Photoshoots,” Bringing Studio-Grade AI Photography to Art-Gen
From GAXOS.AI INC.
Via GlobeNewswire
Tickers GXAI
Terra Innovatum Global to Report Third Quarter 2025 Financial Results and Provide Business Update on November 17, 2025
From Terra Innovatum Global N.V
Via GlobeNewswire
Tickers NKLR
LiveOne (Nasdaq: LVO) to Announce Its Second Quarter Fiscal Year 2026 Financial Results and Host Investor Webcast on November 12, 2025, at 10:00 am Eastern Time (7:00 am Pacific Time)
From LiveOne, Inc.
Via GlobeNewswire
Tickers LVO
UroGen Reports 77.8% Three-Month Complete Response Rate from Phase 3 UTOPIA Trial of UGN-103 and Receives FDA Agreement on NDA Submission Strategy in Recurrent LG-IR-NMIBC Based on UTOPIA Trial
From UroGen Pharma Ltd.
Via GlobeNewswire
Tickers URGN
Mobiquity Technologies’ Platform Powers New Context Networks–NRT Partners to Bring Dynamic Digital Advertising to 1,000+ Casinos Worldwide
From Mobiquity Technologies, Inc.
Via GlobeNewswire
Tickers MOBQ MOBQW
Halper Sadeh LLC Encourages DENN, EVOK, ODP Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
Tickers DENN EVOK ODP
Vericel Reports Third Quarter 2025 Financial Results
From Vericel Corporation
Via GlobeNewswire
Tickers VCEL
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.